Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1995 1
1996 2
1997 2
2003 3
2014 3
2015 3
2016 2
2017 5
2018 1
2019 4
2020 68
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 32371558

92 results
Results by year
Filters applied: . Clear all
Page 1
Hydroxychloroquine use in the COVID-19 patient.
Littlejohn E. Littlejohn E. Cleve Clin J Med. 2020 Jun 18. doi: 10.3949/ccjm.87a.ccc011. Online ahead of print. Cleve Clin J Med. 2020. PMID: 32371558 Free article.
Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
Barnabas RV, Brown E, Bershteyn A, Miller RS, Wener M, Celum C, Wald A, Chu H, Wesche D, Baeten JM; Hydroxychloroquine COVID-19 PEP Study Team. Barnabas RV, et al. Trials. 2020 Jun 3;21(1):475. doi: 10.1186/s13063-020-04446-4. Trials. 2020. PMID: 32493478 Free PMC article. Clinical Trial.
Clinical evidence for repurposing chloroquine and hydroxychloroquine as antiviral agents: a systematic review.
Rodrigo C, Fernando SD, Rajapakse S. Rodrigo C, et al. Clin Microbiol Infect. 2020 Aug;26(8):979-987. doi: 10.1016/j.cmi.2020.05.016. Epub 2020 May 26. Clin Microbiol Infect. 2020. PMID: 32470568 Free PMC article. Review.
Hydroxychloroquine as prophylaxis or treatment for COVID-19: What does the evidence say?
Nina PB, Dash AP. Nina PB, et al. Indian J Public Health. 2020 Jun;64(Supplement):S125-S127. doi: 10.4103/ijph.IJPH_496_20. Indian J Public Health. 2020. PMID: 32496241 Free article. Review.
Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial.
Irvani SSN, Golmohammadi M, Pourhoseingholi MA, Shokouhi S, Darazam IA. Irvani SSN, et al. Trials. 2020 Jun 3;21(1):473. doi: 10.1186/s13063-020-04382-3. Trials. 2020. PMID: 32493468 Free PMC article. Clinical Trial.
Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
Cuadrado-Lavín A, Olmos JM, Cifrian JM, Gimenez T, Gandarillas MA, García-Saiz M, Rebollo MH, Martínez-Taboada V, López-Hoyos M, Fariñas MC, Crespo J. Cuadrado-Lavín A, et al. Trials. 2020 Jun 3;21(1):472. doi: 10.1186/s13063-020-04400-4. Trials. 2020. PMID: 32493494 Free PMC article. Clinical Trial.
Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19.
Yu B, Li C, Chen P, Zhou N, Wang L, Li J, Jiang H, Wang DW. Yu B, et al. Sci China Life Sci. 2020 May 15:1-7. doi: 10.1007/s11427-020-1732-2. Online ahead of print. Sci China Life Sci. 2020. PMID: 32418114 Free PMC article.
Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial.
Sivapalan P, Ulrik CS, Bojesen RD, Lapperre TS, Eklöf JV, Håkansson KEJ, Browatzki A, Tidemansen C, Wilcke JT, Janner J, Gottlieb V, Meteran H, Porsbjerg C, Madsen BL, Moberg M, Pedersen L, Benfield TL, Lundgren JD, Knop FK, Biering-Sørensen T, Ghanizada M, Sonne TP, Bødtger UCS, Jensen SG, Rasmussen DB, Brøndum E, Tupper OD, Sørensen SW, Alstrup G, Laursen CB, Møller UW, Sverrild A, Jensen JS. Sivapalan P, et al. Trials. 2020 Jun 10;21(1):513. doi: 10.1186/s13063-020-04409-9. Trials. 2020. PMID: 32522282 Free PMC article. Clinical Trial.
92 results
Jump to page
Feedback